Showing results (1371-1380 of 4,380) with videos related to
Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|June 18, 2025
Optimized Parenteral and Intranasal Formulations of Tryptamine Psychedelics for Rapid-Acting Antidepressant TherapyRobert B KargboACS Medicinal Chemistry Letters|June 18, 2025
Benzosuberene and Tetracyclic Analogues as Colchicine Site Inhibitors of Tubulin PolymerizationJennifer M VanNatta, Graham J Carlson, Haichan Niu, et al.ACS Medicinal Chemistry Letters|June 18, 2025
Synthesis and Application of Novel Arginine Vasopressin Receptor 1A (AVPR1A) AntagonistsXin Zhou, Steven H LiangACS Medicinal Chemistry Letters|June 18, 2025
Targeting Werner Syndrome Helicase with Small Molecules in Mismatch Repair-Deficient CancersRobert B KargboACS Medicinal Chemistry Letters|June 18, 2025
Targeting KRAS G12D and G10 Mutations with Novel Small Molecule InhibitorsRobert B KargboACS Medicinal Chemistry Letters|June 18, 2025
Enhanced Gram-Negative Membrane Disruption and In Vivo Efficacy via Lysine-Arginine Enrichment of Opis16aMandelie van der Walt, Carel B Oosthuizen, Miruna Serian, et al.ACS Medicinal Chemistry Letters|June 18, 2025
Synthetic Lethality as Emerging Treatment for Cancer: An Example by Using the Werner Syndrome Helicase (WRN) InhibitorsAhmed F Abdel-MagidACS Medicinal Chemistry Letters|June 18, 2025
Optimization of Brain Penetrant SARM1 Orthosteric Inhibitors and Discovery of Their Paradoxical Subinhibitory ActivationSamantha A Green, Russell T Smith, Jessica M Grandner, et al.ACS Medicinal Chemistry Letters|July 16, 2025
Identification of a Novel Indolizine RORγT Inverse Agonist Using the AI-Driven Drug Design PlatformRafał A Bachorz, Joanna Pastwińska, Michael S Lawless, et al.ACS Medicinal Chemistry Letters|July 16, 2025
Novel Heterocyclic Compounds as SMN2 Modulators for Treating Spinal Muscular Atrophy Via Modulation of SMN2 SplicingRam W SabnisPageof 438